BioMarin Pharmaceutical Inc.’s Post

View organization page for BioMarin Pharmaceutical Inc., graphic

168,722 followers

Our leadership in developing medicines for children with growth-related conditions is driven by a deep understanding of science. At the core is C-type natriuretic peptide (CNP), a master regulator of bone growth. Across the spectrum of human height, we learned that naturally higher or lower levels of CNP lead to taller or shorter stature, similar to a “dimmer knob” that can control your lighting. While FGFR is also involved in bone growth, its effects are more like an “on-off switch,” which can’t be fine-tuned in the same way. Our research into CNP is evaluating how it can target a particular cellular signal to seek a specific effect while minimizing off-target effects. Learn more about our science-driven approach: https://bit.ly/4cvb5lf

Cali Mangel

Digital Healthcare Communication + Strategy | MAHF Future Famer 2021 | HBA Rising Star 2023 🏅

1mo

I was just reading this article earlier today and really appreciated the metaphor of this image!

Like
Reply

To view or add a comment, sign in

Explore topics